Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Foidart

Showing results (441-450 of 453) with videos related to

Pageof 46
Sort By:
Protein Expression and Purification|May 25, 1999
Purification of active matrix metalloproteinase catalytic domains and its use for screening of specific stromelysin-3 inhibitorsR Kannan, M Ruff, J G Kochins, et al.
Placenta|September 29, 2004
Fetal growth restriction: a workshop reportI Cetin, J-M Foidart, M Miozzo, et al.
Breast (Edinburgh, Scotland)|December 9, 2003
Effects of a progestogen on normal human breast epithelial cell apoptosis in vitro and in vivoJ Desreux, F Kebers, A Noël, et al.
The Journal of Cell Biology|April 29, 1998
In vivo evidence that the stromelysin-3 metalloproteinase contributes in a paracrine manner to epithelial cell malignancyR Masson, O Lefebvre, A Noël, et al.
Gynecologie, Obstetrique & Fertilite|May 27, 2009
[Current debates on immunology of preeclampsia. Report of the sixth international workshop of Reunion Island (Indian Ocean, December 2008)]P-Y Robillard, G Chaouat, P Le Bouteiller, et al.
Biochemical and Biophysical Research Communications|September 14, 2001
Induction of SPARC by VEGF in human vascular endothelial cellsY Kato, J M Lewalle, Y Baba, et al.
Breast (Edinburgh, Scotland)|December 6, 2007
Safety of tibolone in the treatment of vasomotor symptoms in breast cancer patients--design and baseline data 'LIBERATE' trialP Kenemans, E Kubista, J M Foidart, et al.
Oncogene|March 9, 2010
Higher sensitivity of Adamts12-deficient mice to tumor growth and angiogenesisM El Hour, A Moncada-Pazos, S Blacher, et al.
Carcinogenesis|August 30, 2008
Reduction of brain metastases in plasminogen activator inhibitor-1-deficient mice with transgenic ocular tumorsC M Maillard, C Bouquet, M M Petitjean, et al.
The Journal of Cell Biology|March 27, 2001
The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategiesK Bajou, V Masson, R D Gerard, et al.
Pageof 46

Showing results (441-450 of 453) with videos related to

Sort By:
Pageof 46
Protein Expression and Purification|May 25, 1999
Purification of active matrix metalloproteinase catalytic domains and its use for screening of specific stromelysin-3 inhibitorsR Kannan, M Ruff, J G Kochins, et al.
Placenta|September 29, 2004
Fetal growth restriction: a workshop reportI Cetin, J-M Foidart, M Miozzo, et al.
Breast (Edinburgh, Scotland)|December 9, 2003
Effects of a progestogen on normal human breast epithelial cell apoptosis in vitro and in vivoJ Desreux, F Kebers, A Noël, et al.
The Journal of Cell Biology|April 29, 1998
In vivo evidence that the stromelysin-3 metalloproteinase contributes in a paracrine manner to epithelial cell malignancyR Masson, O Lefebvre, A Noël, et al.
Gynecologie, Obstetrique & Fertilite|May 27, 2009
[Current debates on immunology of preeclampsia. Report of the sixth international workshop of Reunion Island (Indian Ocean, December 2008)]P-Y Robillard, G Chaouat, P Le Bouteiller, et al.
Biochemical and Biophysical Research Communications|September 14, 2001
Induction of SPARC by VEGF in human vascular endothelial cellsY Kato, J M Lewalle, Y Baba, et al.
Breast (Edinburgh, Scotland)|December 6, 2007
Safety of tibolone in the treatment of vasomotor symptoms in breast cancer patients--design and baseline data 'LIBERATE' trialP Kenemans, E Kubista, J M Foidart, et al.
Oncogene|March 9, 2010
Higher sensitivity of Adamts12-deficient mice to tumor growth and angiogenesisM El Hour, A Moncada-Pazos, S Blacher, et al.
Carcinogenesis|August 30, 2008
Reduction of brain metastases in plasminogen activator inhibitor-1-deficient mice with transgenic ocular tumorsC M Maillard, C Bouquet, M M Petitjean, et al.
The Journal of Cell Biology|March 27, 2001
The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategiesK Bajou, V Masson, R D Gerard, et al.
Pageof 46